Published in Urol Oncol on November 19, 2007
Virilizing adrenocortical oncocytoma in a child: a case report. J Korean Med Sci (2010) 0.95
Adrenal tumours are more predominant in females regardless of their histological subtype: a review. World J Urol (2013) 0.91
Adrenocortical oncocytic carcinoma with recurrent metastases: a case report and review of the literature. World J Surg Oncol (2008) 0.90
Imaging appearance of bulk fat within an oncocytic adrenocortical neoplasm, a rare and potentially malignant tumour. Br J Radiol (2010) 0.88
Adrenocortical oncocytoma: Review of imaging and histopathological implications. Int J Surg Case Rep (2010) 0.87
[Not Available]. Can Urol Assoc J (2008) 0.81
Retroperitoneal oncocytoma: case report and review of the imaging features. Br J Radiol (2011) 0.75
Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst (2005) 4.51
A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys (2002) 2.09
The importance of the conformality, heterogeneity, and gradient indices in evaluating Gamma Knife radiosurgery treatment plans for intracranial meningiomas. Int J Radiat Oncol Biol Phys (2011) 2.03
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320. Int J Radiat Oncol Biol Phys (2013) 2.02
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol (2013) 1.88
Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article. J Neurosurg (2011) 1.70
Treatment of heterotopic ossification. Orthopedics (2007) 1.49
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme. J Neurooncol (2009) 1.48
Stereotactic radiosurgery with and without whole-brain radiotherapy for newly diagnosed brain metastases. Expert Rev Neurother (2005) 1.47
Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases. J Neurosurg (2006) 1.47
Postoperative single-fraction radiation for prevention of heterotopic ossification of the elbow. Int J Radiat Oncol Biol Phys (2010) 1.40
Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study. Int J Radiat Oncol Biol Phys (2002) 1.28
Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases. Neuro Oncol (2011) 1.17
Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg (2006) 1.15
Stereotactic radiosurgery for single brainstem metastases: the cleveland clinic experience. Int J Radiat Oncol Biol Phys (2010) 1.14
Current treatment strategies for brain metastasis and complications from therapeutic techniques: a review of current literature. Am J Clin Oncol (2010) 1.14
Treatment of five or more brain metastases with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys (2011) 1.14
Radiotherapy for vestibular schwannomas: a critical review. Int J Radiat Oncol Biol Phys (2011) 1.08
Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older. Cancer (2012) 1.08
Challenges with the diagnosis and treatment of cerebral radiation necrosis. Int J Radiat Oncol Biol Phys (2013) 1.08
Five-year survivors of brain metastases: a single-institution report of 32 patients. Int J Radiat Oncol Biol Phys (2006) 1.07
Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery. J Neurooncol (2012) 1.07
Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study. Anticancer Res (2003) 1.06
Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131. Neuro Oncol (2008) 1.06
Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy. Cancer (2008) 1.06
Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution. Int J Radiat Oncol Biol Phys (2009) 1.04
Recurrent head-and-neck chemodectomas: a comparison of surgical and radiotherapeutic results. Int J Radiat Oncol Biol Phys (2002) 1.04
Failure of gamma knife radiosurgery for mesial temporal lobe epilepsy: report of five cases. Neurosurgery (2004) 1.04
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group. Lancet Oncol (2013) 1.03
Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group. Lancet Oncol (2013) 1.03
Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma. J Neurosurg Spine (2012) 1.03
Brain metastases from bladder carcinoma: presentation, treatment and survival. J Urol (2002) 1.02
RPA classification has prognostic significance for surgically resected single brain metastasis. Int J Radiat Oncol Biol Phys (2006) 0.99
Recursive partitioning analysis index is predictive for overall survival in patients undergoing spine stereotactic body radiation therapy for spinal metastases. Int J Radiat Oncol Biol Phys (2011) 0.99
Symptomatic pituitary metastases from renal cell carcinoma. Pituitary (2007) 0.98
Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤ 6 brain metastases: a multi-institutional phase II trial. J Neurooncol (2011) 0.98
Resectable brain metastases. J Clin Oncol (2006) 0.97
Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018. Int J Radiat Oncol Biol Phys (2004) 0.97
Multidisciplinary management of colorectal brain metastases: a retrospective study. Cancer (2008) 0.96
Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: a retrospective study. Int J Radiat Oncol Biol Phys (2004) 0.95
Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2005) 0.95
Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases. Int J Radiat Oncol Biol Phys (2006) 0.95
Brain metastases in small cell lung cancer. Oncology (Williston Park) (2004) 0.94
Gamma knife radiosurgery for glomus jugulare tumors: volumetric analysis in 17 patients. Neurosurgery (2006) 0.92
Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases. World Neurosurg (2009) 0.92
External beam radiation helps prevent heterotopic bone formation in patients with a history of heterotopic ossification. J Arthroplasty (2006) 0.91
American College of Radiology appropriateness criteria on multiple brain metastases. Int J Radiat Oncol Biol Phys (2009) 0.91
Principal risk of peritumoral edema after stereotactic radiosurgery for intracranial meningioma is tumor-brain contact interface area. Neurosurgery (2010) 0.91
Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery. J Neurooncol (2004) 0.91
Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience. Am J Clin Oncol (2015) 0.90
The role of 111indium-octreotide brain scintigraphy in the diagnosis of cranial, dural-based meningiomas. J Neurooncol (2006) 0.89
ACR Appropriateness Criteria: single brain metastasis. Curr Probl Cancer (2010) 0.89
Stereotactic radiosurgical treatment of brain metastases in older patients. Cancer (2008) 0.89
Review of cranial radiotherapy-induced vasculopathy. J Neurooncol (2015) 0.88
Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS. J Neurooncol (2013) 0.88
Radiotherapy for prolactin-secreting pituitary tumors. Pituitary (2012) 0.87
Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases. Lung Cancer (2012) 0.87
Intraoperative radiation therapy with the photon radiosurgery system in locally advanced and recurrent rectal cancer: retrospective review of the Cleveland clinic experience. Radiat Oncol (2012) 0.87
Gliomatosis cerebri: treatment results with radiotherapy alone. Cancer (2002) 0.86
Factors associated with improved survival in patients with brain metastases from esophageal cancer: a retrospective review. Technol Cancer Res Treat (2003) 0.86
The role of adjuvant radiation therapy in the treatment of spinal myxopapillary ependymomas. J Neurosurg Spine (2010) 0.85
Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults. J Neurooncol (2008) 0.85
Marginal recurrence requiring salvage radiotherapy after stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys (2011) 0.84
Review of the treatment of trigeminal neuralgia with gamma knife radiosurgery. Stereotact Funct Neurosurg (2008) 0.84
Reduction of false-negative results in inferior petrosal sinus sampling with simultaneous prolactin and corticotropin measurement. Endocr Pract (2011) 0.84
Stage III non-small cell lung cancer and metachronous brain metastases. J Thorac Cardiovasc Surg (2002) 0.84
Long-term outcomes of Gamma Knife radiosurgery in patients with vestibular schwannomas. J Neurosurg (2010) 0.84
Stereotactic radiosurgical treatment of parenchymal brain metastases from prostate adenocarcinoma. Surg Neurol (2008) 0.84
Radiation therapy for Cushing's disease: a review. Pituitary (2002) 0.83
Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classification. Int J Radiat Oncol Biol Phys (2009) 0.82
Gamma knife radiosurgery for trigeminal neuralgia: comparing the use of a 4-mm versus concentric 4- and 8-mm collimators. Stereotact Funct Neurosurg (2004) 0.81
Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival. Int J Radiat Oncol Biol Phys (2006) 0.81
Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort. Int J Radiat Oncol Biol Phys (2008) 0.81
Posterior fossa metastases: aggressive treatment improves survival. Stereotact Funct Neurosurg (2003) 0.80
Calvarial and skull base metastases: expanding the clinical utility of Gamma Knife surgery. J Neurosurg (2014) 0.80
Stereotactic radiosurgical treatment of brain metastases to the choroid plexus. Int J Radiat Oncol Biol Phys (2011) 0.80
Increased expression of 5-lipoxygenase in high-grade astrocytomas. Neurosurgery (2006) 0.80
Role of Gamma Knife surgery in patients with 5 or more brain metastases. J Neurosurg (2012) 0.80
Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary results. Technol Cancer Res Treat (2005) 0.79
Long-term survival and functional status of patients with low-grade astrocytoma of spinal cord. Int J Radiat Oncol Biol Phys (2005) 0.79
Impact of preexisting tumor necrosis on the efficacy of stereotactic radiosurgery in the treatment of brain metastases in women with breast cancer. Cancer (2011) 0.79
Stereotactic radiosurgery and radiation therapy for spinal tumors. Expert Rev Neurother (2007) 0.79
Repeat trigeminal nerve radiosurgery for refractory cluster headache fails to provide long-term pain relief. Headache (2007) 0.78
Prospective study of the short-term adverse effects of gamma knife radiosurgery. Technol Cancer Res Treat (2012) 0.78
Long-term results of radiosurgery for refractory cluster headache. Neurosurgery (2006) 0.78
Using higher isodose lines for gamma knife treatment of 1 to 3 brain metastases is safe and effective. Neurosurgery (2014) 0.78
Intensity-modulated radiotherapy for pituitary adenomas: the preliminary report of the Cleveland Clinic experience. Int J Radiat Oncol Biol Phys (2006) 0.78
Management of recurrent brain metastasis after radiosurgery. Prog Neurol Surg (2012) 0.77
Brachytherapy for intracranial meningioma using a permanently implanted iodine-125 seed. Stereotact Funct Neurosurg (2002) 0.77
Gamma knife stereotactic radiosurgery for the management of incidentally-identified brain metastasis from non-small cell lung cancer. J Neurooncol (2011) 0.77
Intraoperative radiotherapy to treat newly diagnosed solitary brain metastasis: initial experience and long-term outcomes. J Neurosurg (2015) 0.77
Primary central nervous system lymphoma in the elderly: the Cleveland clinic experience. Anticancer Res (2013) 0.77
331 Association Between Radiation Necrosis and Tumor Biology Following Stereotactic Radiosurgery for Brain Metastasis. Neurosurgery (2016) 0.76
Relationship between HER2 status and prognosis in women with brain metastases from breast cancer. Int J Radiat Oncol Biol Phys (2011) 0.76
Brain metastases from gynecological cancers: factors that affect overall survival. Technol Cancer Res Treat (2002) 0.75
Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas. J Neurooncol (2010) 0.75
The incidence of second brain tumors related to cranial irradiation. Expert Rev Anticancer Ther (2014) 0.75